EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Weissella confusa RY-1 ameliorates DSS-induced colitis by restoring intestinal barrier, modulating gut microbiota, and reprogramming microbial metabolism

Huaqin Hu, Xin Yao, Huan Zhou, Lu Wang, Bin Peng, Changjin Liu, Shilu Luo, Jian Huang, Xun Min

Frontiers in Microbiology · 05.08.2026 · 17

DOI: 10.3389/fmicb.2026.1896924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 05.08.2026. Verfasst von Huaqin Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) remains a challenging chronic inflammatory bowel disease with limited treatment options. This study investigates the protective role of Weissella confusa RY-1, a potential probiotic strain isolated from human gastric fluid, in a dextran sulfate sodium (DSS)-induced murine colitis model. Administration of W. confusa RY-1 significantly ameliorated colitis symptoms in mice subjected to a 10-day colitis induction model, as demonstrated by improved body weight recovery, reduced disease activity index (DAI) scores, attenuated colon shortening, and restored colonic histoarchitecture. The probiotic treatment enhanced intestinal barrier integrity through upregulation of tight junction proteins ZO-1 and Occludin. 16S rRNA sequencing revealed substantial modulation of gut microbiota, characterized by reduced abundance of pro-inflammatory Escherichia-Shigella and enrichment of beneficial Akkermansia . Metabolomic analysis further demonstrated metabolic reshaping with elevated anti-inflammatory linoleic acid and decreased succinic acid levels. These findings collectively indicate that W. confusa RY-1 exerts protective effects against colitis through multiple mechanisms including barrier reinforcement, microbiota modulation, and metabolic reprogramming, suggesting its promising potential as a novel probiotic-based intervention for ulcerative colitis.

Schlagwörter

Stichwörter der Autor:innen

W. confusa RY-1intestinal barrierintestinal florametabolismulcerative colitis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
  • School of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Zitieren

APA

Hu, H., Yao, X., Zhou, H., Wang, L., Peng, B., Liu, C., Luo, S., Huang, J., & Min, X. (2026). Weissella confusa RY-1 ameliorates DSS-induced colitis by restoring intestinal barrier, modulating gut microbiota, and reprogramming microbial metabolism. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1896924

Vancouver

Hu H, Yao X, Zhou H, Wang L, Peng B, Liu C, et al. Weissella confusa RY-1 ameliorates DSS-induced colitis by restoring intestinal barrier, modulating gut microbiota, and reprogramming microbial metabolism. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1896924

BibTeX
@article{Hu2026,
  author = {Hu, Huaqin and Yao, Xin and Zhou, Huan and Wang, Lu and Peng, Bin and Liu, Changjin and Luo, Shilu and Huang, Jian and Min, Xun},
  title = {Weissella confusa RY-1 ameliorates DSS-induced colitis by restoring intestinal barrier, modulating gut microbiota, and reprogramming microbial metabolism},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1896924}
}
Kostenlos starten →